Table 2.
Analysis of patient and controls cytokine profile.
| Analyte | Control (n = 6) | Patient |
|---|---|---|
| Immunoregulatory | ||
| IL-1b | 19.6 ± 4.9 | 18.1 |
| IL-1RA | 376.2 ± 162.7 | 291.7 |
| IL-2 | 129 ± 17.9 | 78∗ |
| IL-4 | 78.8 ± 5.0 | 87 |
| IL-5 | 1.5 ± 0.3 | 0.7 ± 0.5 |
| IL-6 | 67.3 ± 21.0 | 46.9 |
| IL-7 | 2.5 ± 1.3 | 3.5 ± 1.5 |
| IL-9 | 80.4 ± 9.9 | 89 |
| IL-12 (p70) | 31.1 ± 1.0 | 23 |
| IL-10 | 31.7 ± 3.7 | 95∗ |
| IL-13 | 59.3 ± 5.4 | 35 |
| IL-15 | 131.3 ± 34.3 | 160.1 |
| IL-17 | 3826.8 ± 367.7 | 5483∗ |
| CCL11 | 4314.4 ± 1320.2 | 1984∗ |
| IFN-γ | 2960.3 ± 468.7 | 2391 |
|
| ||
| Leukocyte chemoattractants | ||
| CCL2 | 444.9 ± 132.9 | 926.2∗ |
| CCL3 | 23.3 ± 2.4 | 18 |
| CCL4 | 615.2 ± 147.8 | 453.4 |
| CCL5 | 40267.4 ± 1767.8 | 60422.1 |
| CXCL10 | 7446.1 ± 1865.6 | 9446.9∗ |
| G-CSF | 111.9 ± 20.1 | 202.9∗ |
| GM-CSF | 80.7 ± 22.8 | 56 |
| IL-8 | 370.6 ± 170.7 | 37.3∗ |
| TNF-α | 229.2 ± 22.6 | 210 |
|
| ||
| Angiogenesis | ||
| VEGF | 2367.1 ± 705.7 | 856 |
| PDGF-BB | 34535.4 ± 2952.9 | 39325.6 |
| bFGF | 2.4 ± 1.4 | 1.8 ± 0.9 |
∗Values differ considerably from that in the control.